Teva CEO on Drug Pipeline, Direct Listing on NYSE

Teva Pharmaceuticals CEO Richard Francis discussed the company's second-quarter earnings results, anticipated changes to Medicare reimbursement rules, and the company's listing on the New York Stock Exchange in an interview with Bloomberg.

Next story